Award
National Cancer Institute 5R01CA291826-02
Molecular subtyping of brain tumors using a blood-based multiplexed assay
Recipient
Massachusetts General Hospital
Award Amount
$637,162.00
Ceiling
$637,162.00
Awarded
May 12, 2026
Identifier
5R01CA291826-02
Award for developing a blood-based multiplexed assay to subtype brain tumors molecularly, aiding diagnosis and monitoring.
Description
This project aims to develop and validate a blood-based multiplexed assay for molecular subtyping of gliomas, with potential clinical applications in diagnosis, stratification, and monitoring of brain tumors.